Literature DB >> 21945894

Regulation of endothelial cell development by ETS transcription factors.

Stryder M Meadows1, Candace T Myers, Paul A Krieg.   

Abstract

The ETS family of transcription factors plays an essential role in controlling endothelial gene expression. Multiple members of the ETS family are expressed in the developing endothelium and evidence suggests that the proteins function, to some extent, redundantly. However, recent studies have demonstrated a crucial non-redundant role for ETV2, as a primary player in specification and differentiation of the endothelial lineage. Here, we review the contribution of ETS factors, and their partner proteins, to the regulation of embryonic vascular development.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945894      PMCID: PMC3263765          DOI: 10.1016/j.semcdb.2011.09.009

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  99 in total

1.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.

Authors:  B Wasylyk; C Wasylyk; P Flores; A Begue; D Leprince; D Stehelin
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

2.  Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.

Authors:  H Dudek; R V Tantravahi; V N Rao; E S Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

3.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

4.  Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.

Authors:  I G Maroulakou; T S Papas; J E Green
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

5.  A direct physical association between ETS and AP-1 transcription factors in normal human T cells.

Authors:  A G Bassuk; J M Leiden
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

6.  Xl-fli, the Xenopus homologue of the fli-1 gene, is expressed during embryogenesis in a restricted pattern evocative of neural crest cell distribution.

Authors:  D Meyer; C M Wolff; P Stiegler; F Sénan; N Befort; J J Befort; P Remy
Journal:  Mech Dev       Date:  1993-12       Impact factor: 1.882

7.  Myb and Ets proteins cooperate to transactivate an early myeloid gene.

Authors:  L H Shapiro
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

8.  Endothelial-specific gene expression directed by the tie gene promoter in vivo.

Authors:  J Korhonen; I Lahtinen; M Halmekytö; L Alhonen; J Jänne; D Dumont; K Alitalo
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

9.  The c-ets-1 proto-oncogenes in Xenopus laevis: expression during oogenesis and embryogenesis.

Authors:  P Stiegler; C M Wolff; D Meyer; F Sénan; M Durliat; J Hourdry; N Befort; P Remy
Journal:  Mech Dev       Date:  1993-05       Impact factor: 1.882

10.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts.

Authors:  O Delattre; J Zucman; T Melot; X S Garau; J M Zucker; G M Lenoir; P F Ambros; D Sheer; C Turc-Carel; T J Triche
Journal:  N Engl J Med       Date:  1994-08-04       Impact factor: 91.245

View more
  40 in total

1.  Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.

Authors:  Michael P Craig; Viktorija Grajevskaja; Hsin-Kai Liao; Jorune Balciuniene; Stephen C Ekker; Joo-Seop Park; Jeffrey J Essner; Darius Balciunas; Saulius Sumanas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-26       Impact factor: 8.311

2.  Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures.

Authors:  Yanshu Wang; Mark F Sabbagh; Xiaowu Gu; Amir Rattner; John Williams; Jeremy Nathans
Journal:  Elife       Date:  2019-04-01       Impact factor: 8.140

Review 3.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

4.  HIPK2 is necessary for type I interferon-mediated antiviral immunity.

Authors:  Lili Cao; Guang Yang; Shandian Gao; Chunxia Jing; Ruth R Montgomery; Yuxin Yin; Penghua Wang; Erol Fikrig; Fuping You
Journal:  Sci Signal       Date:  2019-03-19       Impact factor: 8.192

5.  Linking Vascular Remodeling and Inflammation in Pulmonary Arterial Hypertension: Is There a Common Root Cause?

Authors:  Patricia A Thistlethwaite
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

Review 6.  Endothelial Progenitor Cells for the Vascularization of Engineered Tissues.

Authors:  Erica B Peters
Journal:  Tissue Eng Part B Rev       Date:  2017-07-03       Impact factor: 6.389

7.  Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells.

Authors:  Mark F Sabbagh; Jacob S Heng; Chongyuan Luo; Rosa G Castanon; Joseph R Nery; Amir Rattner; Loyal A Goff; Joseph R Ecker; Jeremy Nathans
Journal:  Elife       Date:  2018-09-06       Impact factor: 8.140

8.  Endothelial Erg expression is required for embryogenesis and vascular integrity.

Authors:  Rong Han; Maurizio Pacifici; Masahiro Iwamoto; Maria Trojanowska
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

9.  Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineages.

Authors:  Xiaozhong Shi; Jai Richard; Katie M Zirbes; Wuming Gong; Gufa Lin; Michael Kyba; Jamie A Thomson; Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Dev Biol       Date:  2014-02-26       Impact factor: 3.582

Review 10.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.